Skip to main content
Sign In
 

Karen F. Corsi, ScD, MPH

Associate Professor


Contact Info:
Project Safe
Phone:  303-315-0951
Email: Dr. Corsi
 
Clinical/Research Interests:

Dr. Corsi is interested in substance dependence and public health.

Curriculum Vitae

Connecticut College  BA  1990

Johns Hopkins Bloomberg School of Public Health  MPH  1995

Johns Hopkins Bloomberg School of Public Health  ScD  2003

Member, Society for Applied Anthropology (SfAA), 2001 – 2004   

​Member, American Public Health Association (APHA), 2001 – Present  

Member, Delta Omega Public Health Honors Society, 2003 – Present   

Board of Directors, AIDS Coalition for Education (ACE), 2006 – Present  

Member, Center for Global Health, UCDHSC, 2006 – Present     

Associate Member, College on Problems of Drug Dependence (CPDD), 2006 – Present     

Member, Colorado Center for AIDS Research (CFAR) Behavioral Research Program, 2007 – present      

Reviewer, Drug and Alcohol Dependence, 2003                     

Reviewer, Journal of Acquired Immune Deficiency Syndrome(JAIDS), 2003

Reviewer, Patient Preference and Adherence (PPA), 2007              

Reviewer, Journal of the International AIDS Society, 2009

Invited speaker for symposium entitled: Substance abuse, health disparities, gender issues, victimization and risk behavior: What’s been done  and where are we going globally? AIDSImpact Conference, Santa Fe, NM, September 2011.

Elected to the Literature Selection Technical Review Committee (LSTRC) of the National Library of Medicine, NIH, President’s Advisory Commission appointment; Jul 2014 - Jun 2018.

Nominated as Standing member of Scientific Review group Behavioral and Social Consequences of HIV (BSCH): Jul 2014- Jun 2018.

Invited speaker for presentation entitled, “Global HIV Prevention for People Who Inject Drugs” (in Spanish), University Autonoma de Santo Domingo (UASD), Santo Domingo, Dominican Republic, March 2015.

Invited speaker for presentation entitled, “Gender Differences and HIV for PWID in Ukraine.” The 3rd Annual Fishbein Memorial Symposium, AIDSImpact Conference: Behavioral Interventions in the Era of Biomedical Prevention, Amsterdam, Netherlands, July 2015.

Invited to Chair Symposium panel entitled “Take care - care as a global need in HIV”, AIDSImpact Conference: What will it really take to end the epidemic? Cape Town, South Africa, November 2017.  

Active grants:

NIH/NIDA R21 DA 021522-01, Corsi, Karen F. (PI), 5/10/06 –4/30/09, $343,900 (Year 1). 

Reduction of HIV risk and drug use among out-of-treatment methamphetamine users.

Role: Principal Investigator

 

NIH/NIDA R01 DA 16994-S1, Booth, Robert E. (PI), 9/1/03-6/30/09, $ 457,510 (Year 1). 

Reducing HCV/HIV risks Comparing Two Interventions. 

Role: Co-Investigator

 

NIH/NIDA R01 DA 009832-A2,  Booth, Robert E. (PI), 7/15/1995-05/31/2012, $519,610 (Year 11). 

Intervention to Reduce Injection Drug Use.

Role: Co-Investigator

 

NIH/NIDA R01 DA 016994, Booth, Robert E. (PI), 9/1/03 – 8/31/09, $2,849,402 (Year 4). 

Reducing HCV/HIV Risks Comparing Two Interventions.  

Role: Co- Investigator.

 

Previous Grants (since 2000):

SAMHSA/DHHS 1H79-TI15794-03, Corsi, Karen F. (PI), 9/30/03 – 9/29/08 $1,992,113 (Year 4). 

Strengths-Based Case Management and Group Sessions to Enhance Treatment Readiness in Minority Female Crack Smoking Populations.

Role: Principal Investigator

 

NIH/NIDA R01 DA 09832, Corsi, Karen F. (PI),  6/1/95 – 5/31/07, $2,643,286 (No-Cost extension, Year 12). 

Intervention to Reduce Injection Drug Use.

Role: Principal Investigator

 

NIH/NIDA R01 DA 09832-S1, Corsi, Karen F. (PI), 2002-2003, $198,999. 

A Supplemental Application to Assess Interventions to Reduce Injection Drug Use. 

Role: Principal Investigator.

 

NIH/NIDA R01 DA 12813, Corsi, Karen F. (PI), 1999-2003, $1,373,473. 

Antecedents to Risk Behaviors among Drug Users.  Grant RO1 DA12813.  National Institute on Drug Abuse; Role: Principal Investigator.

 

NIH/NIDA R01 DA 12813-S1, Corsi, Karen F. (PI), 2002 – 2004, $112,661.

A Supplemental Application Designed to Assess the Contribution of Psychiatric Co-Morbidity to HIV-Related Risk-Taking Behaviors. 

Role: Principal Investigator.

Selected Peer-Reviewed Publications